A tale of 5 tests. Insurance coverage.
They promise precision in detecting cancer cells, bone breakdown, risk of heart disease, and other maladies. There's just one problem: Many insurers won't pay for these new diagnostic tools, saying they haven't yet proven themselves. "We complain, we write letters," says one doctor, who calls a new Pap test a "quantum leap" from the existing Pap smear. "I'm just a little physician, crying in the woods."
Lawrence
J
J
D001862:Bone Resorption; D001943:Breast Neoplasms / Q000175:diagnosis; D002784:Cholesterol / Q000032:analysis; D019411:Clinical Laboratory Techniques / Q000191:economics* / Q000639:trends; D005260:Female; D006801:Humans; D019458:Insurance Coverage; D008297:Male; D010024:Osteoporosis / Q000175:diagnosis; D065006:Papanicolaou Test; D011471:Prostatic Neoplasms / Q000175:diagnosis; D018570:Risk Assessment; D013673:Technology Assessment, Biomedical / Q000191:economics*; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis; D014626:Vaginal Smears / Q000191:economics
D002784:Cholesterol